(New York, NY) — There are now more than seven-million Americans living with Alzheimer’s disease. Researchers who worked on the Alzheimer’s Association’s 2025 Disease Facts and Figures report, say that’s the highest number the organization has ever recorded.
New York Dr. Nikhil Palekar says two new FDA-approved medications, Lecanemab and Donanemab, are helping to slow the progression of symptoms in people with early stages of the disease. He stresses as the push for a cure continues, there’s also research examining the benefits weight loss drugs could have on targeting brain inflammation to reduce the risk of the disease.
A survey done by the Alzheimer’s Association found 91% of Americans would take a simple test if it were available, such as a blood test, to find out if they were at risk for Alzheimer’s. No such simple test exists now.
